AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2948451
Drug: Etretin therapy
RxNorm normalized name: etretinate
DrugBank: Etretinate (DB00926)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etretin therapy (50 mg/d)
Trial: 2948451
Drug: Etretin therapy
RxNorm normalized name: etretinate
DrugBank: Etretinate (DB00926)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etretin therapy
Trial: 2948451
Drug: Etretin therapy
RxNorm normalized name: etretinate
DrugBank: Etretinate (DB00926)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etretin therapy for six or more months
Trial: 15283938
Drug: Oral hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral hormone replacement therapy (0.625 mg conjugated equine estrogens + 5 mg medroxyprogesterone daily)
Trial: 15283938
Drug: Transdermal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal hormone replacement therapy (50 microg estradiol + 5 mg medroxyprogesterone daily)
Trial: 15283938
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (Tibolone and both hormone replacement therapies)
Trial: 11828945
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m2 and Carboplatin AUC 7
Trial: 11828945
Drug: Paclitaxel 160
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 160 mg/m2 and Carboplatin AUC 6
Trial: 11828945
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m2 and Carboplatin AUC 6
Trial: 3033389
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg bid for 8 days on a 50 mmol sodium diet
Trial: 3033389
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg bid for 8 days on a 200 mmol sodium diet
Trial: 18575157
Drug: Atorvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (20 mg, 40 mg-80 mg)
Trial: 9848888
Drug: Cilostazol 100
RxNorm normalized name: cilostazol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol 100 mg BID for 12 weeks
Trial: 8923572
Drug: 0.56 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.56 g/kg alcohol
Trial: 3180108
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg dexfenfluramine (d‐FF)
Trial: 3180108
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg metergoline (MTG)
Trial: 20609970
Drug: Prandial Technosphere
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prandial Technosphere inhaled insulin plus bedtime insulin glargine
Trial: 20609970
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily premixed biaspart insulin
Trial: 16488299
Drug: ISA247 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISA247 0.5 mg/kg/d
Trial: 16488299
Drug: ISA247 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISA247 1.5 mg/kg/d
Trial: 8607952
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of 0.25% bupivacaine hydrochloride infiltrated around each tonsil
Trial: 1333934
Drug: Sumatriptan (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan (8 mg)
Trial: 1333934
Drug: Sumatriptan (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan (16 mg)
Trial: 1333934
Drug: Morphine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (20 mg)
Trial: 6365107
Drug: Pantethine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantethine (300 mg t.i.d.) in type IIB patients
Trial: 6365107
Drug: Pantethine (first
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantethine (first treatment) in type IIB patients
Trial: 6365107
Drug: Pantethine (first
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantethine (first treatment) in type IV patients
Trial: 30794649
Drug: Women taking
RxNorm normalized name: Arthricare for Women Moisturizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Women taking oral contraceptives
Trial: 30794649
Drug: Women not
RxNorm normalized name: Arthricare for Women Moisturizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Women not taking oral contraceptives
Trial: 29194198
Drug: Latanoprostene bunod
RxNorm normalized name: Latanoprostene bunod
DrugBank: Latanoprostene bunod (DB11660)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Latanoprostene bunod (LBN) 0.024% once daily (qd)
Trial: 29194198
Drug: Timolol maleate
RxNorm normalized name: Timolol Maleate
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol maleate 0.5% twice daily (bid)
Trial: 26707996
Drug: Letrozole 10
RxNorm normalized name: letrozole 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole 10 mg daily for 7 days
Trial: 25163399
Drug: Oral polio
RxNorm normalized name: Oral Polio Vaccine
DrugBank: Oral Polio Vaccine (DB15864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral polio vaccine (OPV0)
Trial: 21801101
Drug: Autologous whole
RxNorm normalized name: Autologous whole blood product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous whole blood (AWB) injections
Trial: 21801101
Drug: Autologous serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous serum (AS) injections
Trial: 19919597
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as Usual with Assessment (TAU+)
Trial: 15661431
Drug: Ketamine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (60 and 120 ng/mL)
Trial: 11757473
Drug: Sustained-release isosorbide-5-mononitrate
RxNorm normalized name: Isosorbide 5-mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release isosorbide-5-mononitrate (IS-5-MN) 100 mg/day
Trial: 9404745
Drug: Placebo MDI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo MDI through a 750‐mL cone‐shaped spacer (2 puffs) and nebulized salbutamol aerosol 0.5 mL in 1.5 mL saline solution (group 1, n=25)
Trial: 9404745
Drug: Salbutamol MDI
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol MDI and 0.5 mL saline solution in 1.5 mL saline solution (group 2, n=25)
Trial: 2826548
Drug: Keyes' method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Keyes' method of non‐surgical therapy
Trial: 25979532
Drug: Chest tube
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chest tube removal at drainage volume of less than 300 ml/day (Group B)
Trial: 25979532
Drug: Chest tube
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chest tube removal at drainage volume of less than 450 ml/day (Group C)
Trial: 25979532
Drug: Chest tube
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chest tube removal at drainage volume of 150 ml/day or less (Group A)
Trial: 11394950
Drug: Worksite physical
RxNorm normalized name: Workvie
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Worksite physical exercise intervention (9 months, supervised, twice a week)
Trial: 8354136
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg ticlopidine twice daily (group 1)
Trial: 8354136
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg aspirin daily (group 2)
Trial: 31883526
Drug: 12 weekly
RxNorm normalized name: elagolix
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12 weekly sessions of non-specialist-delivered Interpersonal Psychotherapy (IPT)
Trial: 31883526
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months of fluoxetine prescribed by a nurse or clinical officer
Trial: 31883526
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (IPT and fluoxetine)
Trial: 26311640
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol 400 µg every 6 hours for a maximum of 4 doses after 200 mg oral mifepristone
Trial: 26311640
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol 400 µg every 3 hours for a maximum of 4 doses after 200 mg oral mifepristone
Trial: 21375163
Drug: Conventional phacoemulsification
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional phacoemulsification with dual infusion technique through irrigating chopper
Trial: 15259288
Drug: Conjugated estrogen
RxNorm normalized name: Conjugated estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogen plus medroxyprogesterone acetate (CE/MPA 0.625 mg/5 mg)
Trial: 15259288
Drug: 17beta‐estradiol plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17beta‐estradiol plus norethisterone acetate (E2/NETA 2 mg/1 mg)
Trial: 15259288
Drug: CE/MPA 0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CE/MPA 0.625 mg/5 mg
Trial: 11334726
Drug: Oxaliplatin 85
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin 85 mg/m(2) every 2 weeks
Trial: 11334726
Drug: Oxaliplatin combined
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin combined with 5-FU 425 mg/m(2)/day and FA 20 mg/m(2)/dayx5 days every 4 weeks
Trial: 9234925
Drug: Cyclophosphamide 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide 600 mg/m2 plus carboplatin 350 mg/m2
Trial: 9234925
Drug: Cyclophosphamide 1000
RxNorm normalized name: cyclophosphamide 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide 1000 mg/m2 plus cisplatin 80 mg/m2
Trial: 2445151
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg nickel (nickel sulphate)
Trial: 2445151
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg cobalt (cobalt sulphate)
Trial: 30993587
Drug: Brentuximab vedotin
RxNorm normalized name: Brentuximab Vedotin
DrugBank: Brentuximab vedotin (DB08870)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Brentuximab vedotin (BV) at doses of 1.8 or 2.4 mg/kg once every three weeks
Trial: 28042070
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (FEC100→taxane) ± bevacizumab
Trial: 25867783
Drug: Daily smartphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily smartphone self-monitoring (n = 34)
Trial: 23713407
Drug: Slow-release triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release triamcinolone and lidocain injection
Trial: 23713407
Drug: Saline and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline and lidocain injection
Trial: 21475252
Drug: LDAC +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDAC + ATO (0.25 mg/kg on days 1-5, 9, and 11 for at least four courses every 4 to 6 weeks)
Trial: 21475252
Drug: LDAC (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDAC (20 mg b.d. for 10 days)
Trial: 18641209
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (100 mg L-theanine + 50 mg caffeine)
Trial: 18641209
Drug: Caffeine alone
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine alone (50 mg)
Trial: 18641209
Drug: L-theanine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-theanine alone (100 mg)
Trial: 12915959
Drug: High calcium
RxNorm normalized name: Nutritional Supplement Oral Liquid [ENSURE HIGH CALCIUM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High calcium skimmed milk (50 g daily, containing 1200 mg calcium)
Trial: 1474173
Drug: dimenhydrinate, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dimenhydrinate, 100 mg
Trial: 1474173
Drug: meclizine, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meclizine, 50 mg
Trial: 6386032
Drug: Superficial radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Superficial radiotherapy as an adjunct to topical therapy
Trial: 29448833
Drug: luseogliflozin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: luseogliflozin 2.5 mg
Trial: 22089958
Drug: Vibrotactile neurofeedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vibrotactile neurofeedback training (15 min daily for 2 weeks)
Trial: 20128284
Drug: Intravenous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous dexamethasone for 4 days along with anti-inflammatory drug
Trial: 20128284
Drug: Placebo along
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo along with anti-inflammatory drug
Trial: 17729433
Drug: Periinterventional prophylactic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periinterventional prophylactic antibiosis (Unacid 3 g or Ciprobay 100 mg for penicillin allergy)
Trial: 11729368
Drug: PEG-hirudin low
RxNorm normalized name: hirudin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG-hirudin low dose (0.1 mg/kg bolus, 0.01 mg/kg/h infusion)
Trial: 11729368
Drug: PEG-hirudin intermediate
RxNorm normalized name: hirudin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG-hirudin intermediate dose (0.15 mg/kg and 0.015 mg/kg/h)
Trial: 11729368
Drug: PEG-hirudin high
RxNorm normalized name: hirudin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG-hirudin high dose (0.2 mg/kg and 0.02 mg/kg/h)
Trial: 11729368
Drug: Heparin (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (control group)
Trial: 1837646
Drug: Recombinant hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hepatitis B vaccine (GenHevac B Pasteur) 20 micrograms administered at birth, 1 month, 2 months, and booster at 12 months; in combination with 100 IU HBIg for high risk group.
Trial: 1837646
Drug: Recombinant hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hepatitis B vaccine (GenHevac B Pasteur) 20 micrograms administered at birth, 1 month, 2 months, and booster at 12 months; alone for low risk group.
Trial: 3063335
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous alizapride (3.5 mg/kg)
Trial: 3063335
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous metoclopramide (1 mg/kg)
Trial: 24944332
Drug: Dual-release hydrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-release hydrocortisone (DR-HC) 20-40 mg once daily
Trial: 24944332
Drug: Thrice-daily hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Thrice-daily hydrocortisone 20-40 mg divided into three daily doses
Trial: 24944332
Drug: Thrice-daily hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Thrice-daily hydrocortisone
Trial: 20816297
Drug: Routine oral
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine oral hygiene instructions with fluoride toothpaste
Trial: 18472682
Drug: Not applicable
RxNorm normalized name: AIR 1000 mL in 1 L NOT APPLICABLE GAS
DrugBank: Urea (DB03904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not applicable (randomized drug assignments)
Trial: 12873958
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic solution with epinephrine (Group E)
Trial: 12873958
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic solution without epinephrine (Group P)
Trial: 1615615
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of cefadroxil once a day for three days
Trial: 1615615
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of nitrofurantoin three times a day for three days
Trial: 6228746
Drug: Gamma-vinyl GABA,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gamma-vinyl GABA, 2 g/day
Trial: 31780017
Drug: N. sativa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N. sativa 5% gel
Trial: 27436275
Drug: Exenatide QW
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide QW 2 mg (self-administered)
Trial: 27436275
Drug: Exenatide QMS
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide QMS 5 mg (caregiver-administered)
Trial: 27436275
Drug: Exenatide QMS
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide QMS 8 mg (caregiver-administered)
Trial: 27436275
Drug: Exenatide QMS
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide QMS 11 mg (caregiver-administered)
Trial: 24831438
Drug: Modified oral
RxNorm normalized name: Food Starch, Modified Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified oral food challenge with doses of roasted peanuts ranging from 3 to 4500 mg of peanut protein
Trial: 24831438
Drug: Modified oral
RxNorm normalized name: Food Starch, Modified Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified oral food challenge
Trial: 22383993
Drug: Daclizumab (anti-IL-2Rα
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclizumab (anti-IL-2Rα monoclonal antibody), given during lymphodepleting temozolomide (TMZ) treatment
Trial: 16143126
Drug: Selenomethionine 200
RxNorm normalized name: selenomethionine 200 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenomethionine 200 microg daily
Trial: 11880968
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (indinavir or nelfinavir with zidovudine and lamivudine)
Trial: 7477806
Drug: Psychopharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychopharmacological treatment (details not provided)
Trial: 2080934
Drug: Calcitonin nasal
RxNorm normalized name: calcitonin nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitonin nasal spray (200 IU intranasal daily for one year)
Trial: 531075
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg oral methadone
Trial: 6770400
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral methadone
Trial: 16757527
Drug: rhGH (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhGH (6 mg daily injection for 3 months)
Trial: 16757527
Drug: Placebo (self-administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (self-administered for 3 months)
Trial: 11522739
Drug: Cooked green
RxNorm normalized name: egg shell, cooked
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooked green banana (250 g/L)
Trial: 11522739
Drug: Pectin (4
RxNorm normalized name: amylopectin (4,5-dihydroxy-1,3-dimethylimdazolidin-2-one cross linked)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pectin (4 g/kg)
Trial: 8280545
Drug: Oral bromfenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bromfenac 10 mg
Trial: 8280545
Drug: Oral bromfenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bromfenac 25 mg
Trial: 29377474
Drug: Eculizumab (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eculizumab (single dose prior to transplantation)
Trial: 25597173
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (200 IU/d) and calcium (600 mg/d)
Trial: 25597173
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (100 mg) and vitamin C (100 mg)
Trial: 20439627
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen (CEE; 0.625 mg/d)
Trial: 12814319
Drug: 2 IMZ
RxNorm normalized name: Imidazole
DrugBank: Imidazole (DB03366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 IMZ implants placed in a single-stage procedure
Trial: 12814319
Drug: 2 IMZ
RxNorm normalized name: Imidazole
DrugBank: Imidazole (DB03366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 IMZ implants placed in the traditional 2-stage procedure